In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RadioTherapeutics Corp.

Division of Boston Scientific Corp.
www.radiotherapeutics.com

Latest From RadioTherapeutics Corp.

Early Development Firms Set the Stage for Medical Devices

The past couple of years have witnessed the formation of more than a dozen companies focused on taking a portfolio of very early stage medical devices to the next level. With good ideas and connections, device industry executives, as an alternative to joining operating companies are increasingly joining incubators where they can keep their hands in device company creation over a number of projects. Whether you call these companies incubators or accelerators, they all share the goal of filling a gap between technology and company creation, and funding. Accelerators can help early stage concepts get the hearing they normally might not get either in the venture capital community, which is prepared to take on clinical and market risk but not technological risk, or large companies, which are focused on maintaining existing businesses. In fact, for certain kinds of broadly-enabling platform technologies that cut across clinical specialties, the incubator/accelerator model makes a lot of sense.
Business Strategies

Rita Medical: Can a Device Pure Play Compete in Oncology?

In interventional oncology, what makes RITA Medical's path particularly challenging is that the company needs to break new ground on at least a couple of levels simultaneously with its radiofrequency ablation (RFA) technology for treating solid tumors. This is not simply a case of convincing customers to substitute a next-generation device for a longstanding favorite product. The company must convince a group of physician customers-medical oncologists, who control these patients-that devices, specifically RFA technology, can play a role in oncology therapy. This when the only treatment regimens these physicians are accustomed to using are drugs and surgery.
Medical Device Business Strategies

Vivant Medical Inc.

Vivant Medical Inc. has developed minimally invasive microwave ablation technology for solid tumors. Vivant believes that its technology---which includes a novel ring-shaped probe--will be faster, safer and more effective than radiofrequency ablation.
Medical Device

Deal Statistics Quarterly, Q4 2001

In Vivo presents another installment of our quarterly review of dealmaking--in this case October to Decemeber 2001. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Boston Scientific Corp.
  • Senior Management
  • Gary Curtis, CEO
  • Contact Info
  • RadioTherapeutics Corp.
    Phone: (408) 745-3200
    1308 Borregas Ave.
    Sunnyvale, CA 94089
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register